Skip to main content

How does Asparlas (calaspargase pegol-mknl) compare to Oncaspar (pegaspargase)?

Medically reviewed by Judith Stewart, BPharm. Last updated on March 19, 2025.

Official Answer by Drugs.com

Asparlas is given no more frequently than every 21 days and Oncaspar is given no more frequently than every 14 days. Oncaspar is can be given intramuscularly or intravenously while Asparlas is only given intravenously.

Asparlas (calaspargase pegol-mknl) and Oncaspar (pegaspargase) are both forms of PEGylated asparaginase indicated for use in the treatment of acute lymphoblastic leukemia (ALL).

Asparlas provides for a longer interval between doses compared to Oncaspar, and has as an extended shelf life.

Asparlas (calaspargase pegol-mknl) Injection

Oncaspar (pegaspargase) Injection

Read next

What is CAR T-cell therapy and how does it work?

CAR T-cell therapy is a personalized treatment that uses a patient's own immune cells to fight certain cancers and autoimmune diseases. By harnessing and reprogramming a patient’s own immune cells, this therapy offers a new option for those who have not responded to conventional treatments. 

Continue reading

What to avoid when taking Gleevec?

  • Talk to your doctor about warnings, side effects, use in pregnancy and possible drug interactions with Gleevec.
  • Take your Gleevec exactly as prescribed by your doctor. Do not use Gleevec if you are pregnant or planning a pregnancy.
  • Take each tablet with a meal and large glass of water to help prevent stomach irritation.
  • Do not use a broken Gleevec tablet. The medicine from a broken pill can be dangerous if it gets in your mouth, eyes, or nose, or on your skin.
  • Do not use grapefruit products while taking Gleevec, unless okayed by your healthcare provider
  • Do not drive or operate machinery until you know how this medicine may affect you. Use caution when driving as Gleevec may cause dizziness, drowsiness or blurred vision.
Continue reading

How much does Blincyto (blinatumomab) cost?

The cost of a Blincyto (blinatumomab) vial is approximately $5,427 per 35 microgram (mcg) single-dose vial for injection. The overall cost for your therapy will also depend upon the length of treatment. Most people do not pay out-of-pocket for the full price of Blincyto. Continue reading

See also:

Related medical questions

Drug information

Related support groups